Greenwich LifeSciences, Inc.

Ownership Transactions Reported by 6 Insiders

Symbol: GLSI on Nasdaq
Industry: Pharmaceutical Preparations
Location: 3992 Bluebonnet Dr, Building 14, Stafford, TX

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+276K	100%	$13.48	+$3.72M
Sells	0
Net	+2	+276K	100%		+$3.72M

Greenwich LifeSciences, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Snehal Patel	CEO and CFO, Director, 10%+ Owner	$76.4M	+$3.68M	+5.06%	Aug 6, 2024
Jaye Thompson	VP Clinical Reg Affairs	$3.97M	+$40.7K	+1.03%	Aug 2, 2024
David McWilliams	Director				Jun 22, 2022
Frank Daugherty	Chief Medical Officer, Director				Jun 22, 2022
Kenneth Hallock	Director				Jun 22, 2022
Eric Rothe	Director				Jun 22, 2022

Recent Insider Transactions by Companies or Individuals for Greenwich LifeSciences, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.